Literature DB >> 7000701

Searches among mycobacterial cultures for antileprosy vaccines.

C C Shepard, R van Landingham, L L Walker.   

Abstract

All mycobacteria species share some antigens, so there may be cultivable mycobacterial cultures that can provide vaccine protection against leprosy. Vaccine protection against Mycobacterium leprae infections in mice has been demonstrated for M. leprae itself, as living or heat-killed suspensions, and for Mycobacterium bovis (BCG), as living suspensions. Results are reported here with 17 other cultures. The mycobacterial suspensions were injected intradermally, and the mice were challenged in the footpad with infectious suspensions of M. leprae. In two experiments the mice were also challenged by footpad injections of 10(7) heat-killed M. leprae so the footpad enlargment could be measured. That some mycobacterial suspensions were immunogenic for some of their own antigens was suggested by reactions at the vaccine site and enlargement of the regional lymph nodes. Some mycobacterial suspensions also stimulated footpad enlargement on challenge by homologous suspensions or by challenge with M. leprae suspensions. Consistent protection against infectious challenge with M. leprae was observed only with BCG and M. leprae, however.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7000701      PMCID: PMC551235          DOI: 10.1128/iai.29.3.1034-1039.1980

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  13 in total

1.  Taxonomic studies on the leprosy bacillus.

Authors:  J L Stanford; G A Rook
Journal:  Int J Lepr Other Mycobact Dis       Date:  1976 Jan-Jun

2.  Early and late reactions in tuberculoid and lepromatous leprosy patients with lepromins from Mycobacterium leprae and five selected cultivable mycobacteria.

Authors:  A S Mustafa; G P Talwar
Journal:  Lepr India       Date:  1978-10

3.  Shared antigens between Mycobacterium bovis (BCG) and neoplastic cells.

Authors:  P Minden; J K McClatchy; M Wainberg; D W Weiss
Journal:  J Natl Cancer Inst       Date:  1974-11       Impact factor: 13.506

4.  Immunoelectronmicroscopic analysis of surface antigens common to Mycobacterium bovis (BCG) and tumor cells.

Authors:  C Bucana; M G Hanna
Journal:  J Natl Cancer Inst       Date:  1974-11       Impact factor: 13.506

5.  Adjuvanticity (immunity-inducing property) of cord factor in mice and rats.

Authors:  R Saito; S Nagao; M Takamoto; K Sugiyama; A Tanaka
Journal:  Infect Immun       Date:  1977-06       Impact factor: 3.441

6.  Immune response to sheep red blood cells in mice pretreated with mycobacterial fractions.

Authors:  A Bekierkunst; E Yarkoni; I Flechner; S Morecki; E Vilkas; E Lederer
Journal:  Infect Immun       Date:  1971-09       Impact factor: 3.441

7.  Immunity to Mycobacterium leprae infections in mice stimulated by M. leprae, BCG, and graft-versus-host reactions.

Authors:  C C Shepard; R Van Landingham; L L Walker
Journal:  Infect Immun       Date:  1976-10       Impact factor: 3.441

8.  Growth and immunogenicity of photochromogenic strains of mycobacteria in the footpads of normal mice.

Authors:  F M Collins; V Montalbine; N E Morrison
Journal:  Infect Immun       Date:  1975-05       Impact factor: 3.441

9.  Attempts to establish the armadillo (Dasypus novemcinctus Linn.) as a model for the study of leprosy. I. Report of lepromatoid leprosy in an experimentally infected armadillo.

Authors:  W F Kirchheimer; E E Storrs
Journal:  Int J Lepr Other Mycobact Dis       Date:  1971 Jul-Sep

10.  Heat stability of Mycobacterium leprae immunogenicity.

Authors:  C C Shepard; L L Walker; R van Landingham
Journal:  Infect Immun       Date:  1978-10       Impact factor: 3.441

View more
  12 in total

1.  Cell mediated immunity cross-reactions of mycobacteria: polymorphism of target bacterial antigens.

Authors:  S Kulkarni; S Hattikudur; R S Kamat
Journal:  Clin Exp Immunol       Date:  1986-01       Impact factor: 4.330

2.  Investigation of antigen cross-reactivity of Mycobacterium leprae-reactive murine T-cell lines and clones.

Authors:  A E Kingston; A J Stagg; M J Colston
Journal:  Immunology       Date:  1986-06       Impact factor: 7.397

3.  Rapid and sensitive detection of Mycobacterium leprae using a nested-primer gene amplification assay.

Authors:  B B Plikaytis; R H Gelber; T M Shinnick
Journal:  J Clin Microbiol       Date:  1990-09       Impact factor: 5.948

4.  Immunological activity of a 14-kilodalton recombinant protein of Mycobacterium tuberculosis H37Rv.

Authors:  A E Kingston; P R Salgame; N A Mitchison; M J Colston
Journal:  Infect Immun       Date:  1987-12       Impact factor: 3.441

Review 5.  Advances and hurdles on the way toward a leprosy vaccine.

Authors:  Malcolm S Duthie; Thomas P Gillis; Steven G Reed
Journal:  Hum Vaccin       Date:  2011-11-01

6.  Cellular immune response to the cell walls of Mycobacterium leprae in leprosy patients and healthy subjects exposed to leprosy.

Authors:  P W Roche; K D Neupane; W J Britton
Journal:  Clin Exp Immunol       Date:  1992-07       Impact factor: 4.330

7.  Induction of delayed-type hypersensitivity in human volunteers immunized with a candidate leprosy vaccine consisting of killed Mycobacterium leprae.

Authors:  H K Gill; A S Mustafa; T Godal
Journal:  Bull World Health Organ       Date:  1986       Impact factor: 9.408

8.  Adoptive cell transfer of resistance to Mycobacterium leprae infections in mice.

Authors:  C Lowe; S J Brett; R J Rees
Journal:  Clin Exp Immunol       Date:  1985-08       Impact factor: 4.330

9.  Heterologous expression of the 65-kilodalton antigen of Mycobacterium leprae and murine T-cell responses to the gene product.

Authors:  F I Lamb; A E Kingston; I Estrada; M J Colston
Journal:  Infect Immun       Date:  1988-05       Impact factor: 3.441

10.  Comparison of the immunogenicity of vaccines prepared from viable Mycobacterium bovis BCG, heat-killed Mycobacterium leprae, and a mixture of the two for normal and M. leprae-tolerant mice.

Authors:  C C Shepard; R M van Landingham; L L Walker; S Z Ye
Journal:  Infect Immun       Date:  1983-06       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.